Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01343784
Other study ID # IRB 11-082
Secondary ID
Status Completed
Phase N/A
First received April 26, 2011
Last updated February 18, 2014
Start date April 2011
Est. completion date December 2013

Study information

Verified date February 2014
Source The Cleveland Clinic
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the incidence of catheterization from discharge to 6 weeks postoperatively when using two methods of post-operative voiding evaluation after a mid-urethral sling procedure. The investigators' results may lead to a decreased use of indwelling catheters and their associated morbidity after outpatient sling surgery.


Description:

Minimally invasive slings have demonstrated similar efficacy to earlier abdominal anti-incontinence procedures, but offer the benefit of shorter operating times, less voiding dysfunction, lower morbidity and are usually done as an outpatient procedure. Despite the advantages, about 35% of patients are discharged home with indwelling catheters. Indwelling catheters are bothersome for patients, costly to the healthcare system and are a source of significant morbidity. The challenge for pelvic surgeons performing anti-incontinence procedures is avoiding postoperative urinary retention while minimizing the use of catheters and their associated risks. A commonly described backfill-assisted voiding trial is used as a means of evaluating bladder function postoperatively. This method uses a low post-void residual as a specific criterion for discharge without a catheter. However, the validity of this method has never been critically evaluated. Our recent observational study suggests that patients may be safely discharged without a catheter after a midurethral sling procedure based on their subjective assessment of the force of stream. Our proposed study expands on this pilot data using a randomized trial to evaluate two methods of post-operative voiding evaluation. The results may lead to a decreased use of indwelling catheters and their associated morbidity after outpatient sling surgery.


Recruitment information / eligibility

Status Completed
Enrollment 105
Est. completion date December 2013
Est. primary completion date December 2013
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 81 Years
Eligibility Enrollment:

All patients,18-81 year old, undergoing an outpatient midurethral sling surgery will be screened for participation in the study at the preoperative visit.

Exclusion:

1. Women undergoing concomitant urinary tract or pelvic reconstructive procedures

2. Women with pelvic organ prolapse beyond the hymen

3. Women who have undergone a different or same procedure for urinary incontinence in the past

4. Women with neurological conditions, such as multiple sclerosis, spinal cord injury/pathology

5. Cases complicated by a cystotomy or other complication necessitating postoperative catheterization

6. Non-English speakers

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Screening


Related Conditions & MeSH terms


Intervention

Other:
Urinary voiding assessment after midurethral sling
Both groups will undergo voiding trial in the similar manner. The decision to discharge based on an objective measure (voided amount) versus based on the subjective measure (force of stream self assessment).

Locations

Country Name City State
United States Cleveland Clinic Beachwood Beachwood Ohio
United States Cleveland Clinic Hillcrest Hospital Mayfield Heights Ohio

Sponsors (1)

Lead Sponsor Collaborator
The Cleveland Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Total Catheterization Rate The incidence of postoperative catheterization (total catheterization) at any point from discharge after surgery to 6 weeks postoperatively.
The incidence of being discharged with an indwelling catheter will be gathered from PACU records. The information regarding catheterization after that point will be captured via the electronic medical records or patient questionnaires (at 2 days, 1 week, and 6 week follow-up).
Surgery to 6-weeks post-operatively Yes
Secondary Subjective assessment of Force of Stream (FOS). Using VAS, the subject compares the post-operative FOS with the pre-operative FOS on a scale of 0-120% given the pre-operative FOS is 100%. 30 minutes to 2 hours in recovery room No
Secondary Number of return visits to the office or to the emergency room This information will be captured via the EMR or the patient questionnaires, at 2-days, 1-week and 6-weeks folow-up. 6 weeks Yes
Secondary Cumulative number of days of catheterization Calculated from EMR at the 6-weeks post-operative visit. 6 weeks Yes
Secondary Incidence of catheter acquired urinary tract infection (CAUTI) UTI is defined according to the CDC as a positive culture >10^5 CFU/ml with no more than 2 species of microorganisms in the patient's endorsing 1 or more UTI symptoms. 6 weeks Yes
Secondary Time to discharge from PACU Collected from EMR. 30 minutes to 2 hours in recovery room No
Secondary Effectiveness of the sling procedure Incontinence severity index will be collected at enrollment and at 6 weeks post surgery. The score will be compared to determine if the procedure was effective at treating incontinence. 6 weeks No
Secondary Postoperative pain Pain scale will be administered at 2-days, 1-week and 6-weeks follow-up. 6 weeks No
Secondary Patient's expectation of postoperative recovery Information will be collected via short survey at enrollment. The subject will be asked to assign a level of importance to post-operative factors such as pain control, prolonged catheterization, daily activities and ability to return to work. Assessed at enrollment, average 10 minutes No
Secondary Daily function postoperatively as well as satisfaction with the surgery Information will be gathered from questionnaires at 2-days, 1-week and 6-weeks follow-up. Modified validated questionnaire will be used (McCarthy et al). 6 weeks No